Lun Zhou1, Jielin Liu2, Patrick Olson2, Ke Zhang3, Joshua Wynne4, Linglin Xie5. 1. Department of Basic Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA; Department of Gerontology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. 2. Department of Basic Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA. 3. Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA. 4. Department of Internal Medicine, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA. 5. Department of Basic Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA. Electronic address: linglin.xie@med.und.edu.
Abstract
RATIONALE: Mutations of TBX5 cause Holt-Oram syndrome (HOS) in humans, a disease characterized by atrial or occasionally ventricular septal defects in the heart and skeletal abnormalities of the upper extremity. Previous studies have demonstrated that Tbx5 regulates Osr1 expression in the second heart field (SHF) of E9.5 mouse embryos. However, it is unknown whether and how Tbx5 and Osr1 interact in atrial septation. OBJECTIVE: To determine if and how Tbx5 and Osr1 interact in the posterior SHF for cardiac septation. METHODS AND RESULTS: In the present study, genetic inducible fate mapping showed that Osr1-expressing cells contribute to atrial septum progenitors between E8.0 and E11.0. Osr1 expression in the pSHF was dependent on the level of Tbx5 at E8.5 and E9.5 but not E10.5, suggesting that the embryo stage before E10.5 is critical for Tbx5 interacting with Osr1 in atrial septation. Significantly more atrioventricular septal defects (AVSDs) were observed in embryos with compound haploinsufficiency for Tbx5 and Osr1. Conditional compound haploinsufficiency for Tbx5 and Osr1 resulted in a significant cell proliferation defect in the SHF, which was associated with fewer cells in the G2 and M phases and a decreased level of Cdk6 expression. Remarkably, genetically targeted disruption of Pten expression in atrial septum progenitors rescued AVSDs caused by Tbx5 and Osr1 compound haploinsufficiency. There was a significant decrease in Smo expression, which is a Hedgehog (Hh) signaling pathway modulator, in the pSHF of Osr1 knockout embryos at E9.5, implying a role for Osr1 in regulating Hh signaling. CONCLUSIONS: Tbx5 and Osr1 interact to regulate posterior SHF cell cycle progression for cardiac septation.
RATIONALE: Mutations of TBX5 cause Holt-Oram syndrome (HOS) in humans, a disease characterized by atrial or occasionally ventricular septal defects in the heart and skeletal abnormalities of the upper extremity. Previous studies have demonstrated that Tbx5 regulates Osr1 expression in the second heart field (SHF) of E9.5 mouse embryos. However, it is unknown whether and how Tbx5 and Osr1 interact in atrial septation. OBJECTIVE: To determine if and how Tbx5 and Osr1 interact in the posterior SHF for cardiac septation. METHODS AND RESULTS: In the present study, genetic inducible fate mapping showed that Osr1-expressing cells contribute to atrial septum progenitors between E8.0 and E11.0. Osr1 expression in the pSHF was dependent on the level of Tbx5 at E8.5 and E9.5 but not E10.5, suggesting that the embryo stage before E10.5 is critical for Tbx5 interacting with Osr1 in atrial septation. Significantly more atrioventricular septal defects (AVSDs) were observed in embryos with compound haploinsufficiency for Tbx5 and Osr1. Conditional compound haploinsufficiency for Tbx5 and Osr1 resulted in a significant cell proliferation defect in the SHF, which was associated with fewer cells in the G2 and M phases and a decreased level of Cdk6 expression. Remarkably, genetically targeted disruption of Pten expression in atrial septum progenitors rescued AVSDs caused by Tbx5 and Osr1 compound haploinsufficiency. There was a significant decrease in Smo expression, which is a Hedgehog (Hh) signaling pathway modulator, in the pSHF of Osr1 knockout embryos at E9.5, implying a role for Osr1 in regulating Hh signaling. CONCLUSIONS:Tbx5 and Osr1 interact to regulate posterior SHF cell cycle progression for cardiac septation.
Authors: B G Bruneau; G Nemer; J P Schmitt; F Charron; L Robitaille; S Caron; D A Conner; M Gessler; M Nemer; C E Seidman; J G Seidman Journal: Cell Date: 2001-09-21 Impact factor: 41.582
Authors: Yusuke Watanabe; Stéphane Zaffran; Atsushi Kuroiwa; Hiroaki Higuchi; Toshihiko Ogura; Richard P Harvey; Robert G Kelly; Margaret Buckingham Journal: Proc Natl Acad Sci U S A Date: 2012-10-23 Impact factor: 11.205
Authors: Laura E Briggs; Aimee L Phelps; Elizabeth Brown; Jayant Kakarla; Robert H Anderson; Maurice J B van den Hoff; Andy Wessels Journal: Circ Res Date: 2013-04-12 Impact factor: 17.367
Authors: Andrew D Hoffmann; Xinan Holly Yang; Ozanna Burnicka-Turek; Joshua D Bosman; Xiaomeng Ren; Jeffrey D Steimle; Steven A Vokes; Andrew P McMahon; Vladimir V Kalinichenko; Ivan P Moskowitz Journal: PLoS Genet Date: 2014-10-30 Impact factor: 5.917
Authors: M Sameer Rana; Magali Théveniau-Ruissy; Christopher De Bono; Karim Mesbah; Alexandre Francou; Mayyasa Rammah; Jorge N Domínguez; Marine Roux; Brigitte Laforest; Robert H Anderson; Timothy Mohun; Stephane Zaffran; Vincent M Christoffels; Robert G Kelly Journal: Circ Res Date: 2014-09-04 Impact factor: 17.367
Authors: Lun Zhou; Jielin Liu; Menglan Xiang; Patrick Olson; Alexander Guzzetta; Ke Zhang; Ivan P Moskowitz; Linglin Xie Journal: Proc Natl Acad Sci U S A Date: 2017-02-06 Impact factor: 11.205
Authors: Jeffrey D Steimle; Scott A Rankin; Christopher E Slagle; Jenna Bekeny; Ariel B Rydeen; Sunny Sun-Kin Chan; Junghun Kweon; Xinan H Yang; Kohta Ikegami; Rangarajan D Nadadur; Megan Rowton; Andrew D Hoffmann; Sonja Lazarevic; William Thomas; Erin A T Boyle Anderson; Marko E Horb; Luis Luna-Zurita; Robert K Ho; Michael Kyba; Bjarke Jensen; Aaron M Zorn; Frank L Conlon; Ivan P Moskowitz Journal: Proc Natl Acad Sci U S A Date: 2018-10-23 Impact factor: 11.205